Xianping Shi Selected Research

Xianping Shi Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 07/2009
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2023 - 03/2009
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 04/2015
2	Ewing Sarcoma (Sarcoma, Ewing) 11/2020 - 01/2019
2	Leukemia 09/2016 - 11/2014
2	Rheumatic Fever (Acute Articular Rheumatism) 10/2014 - 07/2014
1	Nasopharyngeal Carcinoma 12/2021
1	Immune System Diseases (Immune Disorders) 06/2020
1	Multiple Myeloma 02/2017
1	Hyperbilirubinemia 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Carcinogenesis 02/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Rheumatoid Arthritis 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2014
1	Obstructive Sleep Apnea 09/2013
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2012
1	Hematologic Neoplasms (Hematological Malignancy) 04/2012
1	Oncogene Addiction 04/2012
1	Hypertrophy 03/2011
1	Polyploidy 04/2010
1	Chromosomal Instability (Chromosome Stability) 04/2010
1	Systemic Mastocytosis 07/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2009

Drug/Important Bio-Agent (IBA)

10	Imatinib Mesylate (Gleevec)FDA Link 03/2023 - 03/2009
10	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2014
7	Deubiquitinating EnzymesIBA 01/2023 - 07/2014
4	bcr-abl Fusion ProteinsIBA 01/2022 - 01/2014
4	Auranofin (Ridaura)FDA Link 01/2016 - 07/2014
3	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 09/2016
3	CaspasesIBA 01/2017 - 01/2014
3	GoldIBA 01/2016 - 07/2014
3	Antirheumatic Agents (DMARD)IBA 11/2014 - 07/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 01/2017
2	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 12/2022 - 04/2012
2	EWS-FLI fusion proteinIBA 11/2020 - 01/2019
2	platinum pyrithioneIBA 01/2017 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 11/2016 - 02/2016
2	gambogic acidIBA 04/2015 - 01/2014
2	triptolideIBA 07/2009 - 03/2009
1	ElementsIBA 03/2024
1	Histones (Histone)IBA 03/2024
1	RutheniumIBA 03/2023
1	piperlongumineIBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	pseudolaric acid BIBA 06/2020
1	Cysteine (L-Cysteine)FDA Link 11/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 02/2017
1	pyrithione zinc (ZPT)FDA Link 02/2017
1	Ubiquitinated ProteinsIBA 01/2017
1	BilirubinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	NickelIBA 11/2016
1	pyrithioneIBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	PlatinumIBA 09/2016
1	ATP dependent 26S protease (26S proteasome)IBA 09/2016
1	DNA (Deoxyribonucleic Acid)IBA 09/2016
1	Platinum Compounds (Compounds, Platinum)IBA 09/2016
1	MicroRNAs (MicroRNA)IBA 02/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Disulfiram (Antabuse)FDA Link 01/2016
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2016
1	Aldehyde DehydrogenaseIBA 01/2016
1	Bortezomib (Velcade)FDA Link 07/2014
1	LeptinIBA 09/2013
1	Tyrosine Kinase InhibitorsIBA 04/2012
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2012
1	GDP 366IBA 04/2010
1	SurvivinIBA 04/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2009

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2014
4	Drug Therapy (Chemotherapy) 12/2022 - 04/2015
1	Lasers (Laser) 12/2021
1	Photochemotherapy (Photodynamic Therapy) 12/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2020
1	Intraperitoneal Injections 01/2017
1	Aftercare (After-Treatment) 09/2013
1	Adenoidectomy 03/2011
1	Tonsillectomy 03/2011
1	Operative Surgical Procedures 03/2011